As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.
16 Analysts have issued a Avadel Pharmaceuticals PLC Sponsored ADR forecast:
16 Analysts have issued a Avadel Pharmaceuticals PLC Sponsored ADR forecast:
| Sep '25 |
+/-
%
|
||
| Revenue | 249 249 |
80%
80%
|
|
| Gross Profit | 226 226 |
78%
78%
|
|
| EBITDA | -1.30 -1.30 |
98%
98%
|
|
| EBIT (Operating Income) EBIT | -4.98 -4.98 |
92%
92%
|
|
| Net Profit | -0.28 -0.28 |
100%
100%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.
| Head office | Ireland |
| CEO | Gregory Divis |
| Employees | 188 |
| Founded | 2015 |
| Website | www.avadel.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


